Evidence map›Paper›PMID 41332452›Full record

ArticleJugan geon-gang gwa jilbyeong2023

[Status of Malaria and Diagnosis Rate in the Republic of Korea, 2018-2022].

HyunJung Kim, So-Dam Lee, Na-Ri Shin, Kyungwon Hwang

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Jugan geon-gang gwa jilbyeong, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Addressing the Gaps in Malaria Treatment in Korea.Journal of Korean medical science · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

HyunJung Kim질병관리청 감염병정책국 인수공통감염병관리과.
So-Dam Lee질병관리청 감염병정책국 인수공통감염병관리과.
Na-Ri Shin질병관리청 감염병정책국 인수공통감염병관리과.
Kyungwon Hwang질병관리청 감염병정책국 인수공통감염병관리과.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria is a mosquito-borne disease designated as a Class-3 infectious disease in the Republic of Korea (ROK). Since the malaria outbreak in the military camps at Paju, an area near North Korea in 1993, the ROK has continuously witnessed the occurrence of malaria. As per the World Health Organization (WHO), the ROK is a malaria elimination target country, and the Korea Disease Control and Prevention Agency (KCDA) is promoting a five-year (2019-2023) action plan to eliminate malaria. Over the past five years, the number of malaria cases in the ROK have decreased slightly every year since 1998. However, the ROK remains far from malaria elimination, which aims at zero indigenous cases. The action plan aims to analyze the diagnosis rate within five days and initiates epidemiological investigation rate. Most of the malaria cases in the ROK occur mainly between April and October. By region, 59.2% of all cases occur in Gyeonggi-do, and Incheon had the highest incidence rate (2.1) per 100,000 people. Altogether, 64.4% of the total malaria cases have been reported from 30 districts that have been designated as malaria-risk areas. The indicators were found to be 73.6% in the diagnosis rate within five days and 81.7% in the epidemiological investigation rate. In the malaria-risk areas, the disease diagnosis and epidemiological investigations took a shorter time than in other regions. It was confirmed that the time of diagnosis after the onset of malaria symptoms was 4.75 days across the nation. In countries that have been certified by WHO for malaria elimination, rapid diagnosis and treatment are major strategies that have contributed to disease eradication. Thus, various approaches for prevention, diagnosis, and medium management are necessary to eliminate malaria.

Indexed as

Early DiagnosisEpidemiological investigationMalariaVector Borne Diseases

Identifiers

PMID41332452
PMCPMC12480269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.